Skip to main content
Previous Poster Home Next

Assessment of Physician Treatment Preferences for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
07:30am - 03:45pm EST - April 1, 2023

  • Information
  • Resources
  • Play Recording

Assessment of Physician Treatment Preferences for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) icon

https://jnccn.org/view/journal...


Author(s):
  • Betsy J. Lahue, MPH, CEO, Alkemi, LLC

Tags: Outcomes and Health Services Research

Display Label Action
AC23P116 - Assessment of Physician Treatment Preferences for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Download MP3
116-General Poster Sesson Download Handout